Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3
Published November 27, 2024 · Recall initiated: October 31, 2024
Summary
FDA records drug Class II recall D-0055-2025, published November 27, 2024 and initiated October 31, 2024. Recalling firm: Noven Pharmaceuticals Inc; Status: Ongoing; Reported quantity: 685 boxes; Lot: Lot # 95598, Exp 02/28/25. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
What to do
Voluntary: Firm initiated · Letter
Get an email if XELSTRYM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- XELSTRYM
- Manufacturer
- Noven Pharmaceuticals Inc
- Distributor
- USA nationwide.
- Lot
- Lot # 95598, Exp 02/28/25
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARamipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 countNovember 27, 2024
- FDAVitamin D3, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDCNovember 27, 2024
- FDARamipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 countNovember 27, 2024
- FDAVitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDCNovember 27, 2024
- FDARamipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 countNovember 27, 2024
- FDAAspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com,November 27, 2024
Questions about this recall
Was Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3 recalled?
Yes. FDA published recall D-0055-2025 on November 27, 2024. Reported hazard: Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: XELSTRYM.